跳至主要内容
临床试验/IRCT20190302042885N1
IRCT20190302042885N1已完成3 期

Comparison of the efficacy of omega-3 as an adjunctive therapy of sertraline and venlafaxine in improving symptoms of major depressive disorder : A Double-blind , placebo controlled trial

Alborz Univesity of Medical Sience0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Having DSM-V diagnostic criteria for major depressive disorder with clinical diagnosis of psychiatrist
  • Earning a score higher than 7 based on Hamilton's Questionnaire (HAM-D)
  • Obtain informed consent from the patient
  • Age between 18 and 60 years
  • There is no psycho-manifestation

排除标准

  • Drug abuse and drug abuse other than nicotine and caffeine
  • IQ less than 70
  • There is another psychiatric disorder in the diagnostic axis one
  • The presence of a medical condition (especially liver disease, cardiovascular disease and hypertension) or significant neurology

研究者

发起方
Alborz Univesity of Medical Sience

相似试验